AMAG Pharmaceuticals is a specialty pharmaceutical company with a focus on maternal health, anemia, and cancer supportive care. The company markets three key products: Makena, an injection to reduce the risk of preterm birth in singleton pregnancy; Feraheme, an IV iron replacement therapy for adult patients with chronic kidney disease and iron deficiency anemia; and MuGard, an oral wound rinse for the management of oral mucocitis/stomatiits and other types of oral wounds. The company is dedicated to addressing unmet medical needs and improving the lives of patients through innovative solutions.